(Circulation. 1996;93:143-152.)
© 1996 American Heart Association, Inc.
Articles |
Transmural Channels Can Protect Ischemic Tissue
Assessment of Long-term Myocardial Response to Laser- and Needle-MadeChannels
From the Heart Institute, Good Samaritan Hospital, and Department of Medicine, Section of Cardiology, University of Southern California, Los Angeles; and Department of Physiology, University of Ottawa, Canada (K.R.).
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion References |
|---|
Background We previously found that transmural laser channels failed to acutely increase myocardial blood flow. Nevertheless, this method is being used to treat patients with coronary artery disease who are unable to undergo angioplasty or bypass graft surgery and in cases in which previous surgery has failed. To reconcile the lack of an acute increase in blood flow with beneficial effects claimed in patients, our hypothesis was that the channel-making process might, over time, stimulate a protective effect, possibly by the growth of new vessels linking channels to the existing circulation. We tested this hypothesis in rat hearts, which have little native collateral circulation.
Methods and Results We made six transmural channels in the left ventricle of each heart using a 400-µm-diameter optic fiber coupled to a holmium:yttrium-aluminum-garnet laser or a 400-µm-diameter syringe needle. Two months after the channels were made, rats were randomized to either an infarct-size study or analysis of myocardial capillary density. We challenged any induced protective mechanism by acutely occluding the left coronary artery for 90 minutes, followed by 4.5 hours of reperfusion. The artery was then reoccluded, and pigment was injected into the circulation to delineate tissue perfused by the occluded vessel and to detect perfusion via the channels. We used triphenyltetrazolium staining to determine the amount of muscle necrosis and the location of muscle protection. Infarct size in needle-treated hearts was smaller than in controls (15±6% versus 40±3% of the left ventricle, P<.01). Infarct size in laser-treated hearts (27±5%) did not differ significantly from controls; however, all eight laser-treated hearts showed evidence of muscle protection in areas adjacent to channels. We found that the laser-made channels were associated with more fibrosis than the needle-made channels (mean width of fibrosis 430±50 versus 180±30 µm, P<.0001), and, in tissue remote from channels, fibrosis was increased more in laser-treated hearts (3.6±0.3%) versus both control (2.5±0.2%) and needle-treated (2.5±0.3%) hearts (P<.05). In addition, muscle disarray was seen adjacent to channel-associated fibrosis. We observed injected pigment within fibrosis associated with the channels and in surrounding myocardium. We also found vessels that appeared to be connected to channels; however, there was no overall increase in capillary density.
Conclusions We were able to protect the heart against coronary artery occlusion by making transmural channels 2 months before occlusion. Channels created by a needle provided greater protection than channels created by a laser, probably because they caused less initial injury. Our results are consistent with the concept that the channels were able to provide blood flow to the tissue directly from the ventricular cavity; however, we cannot rule out the possibility that other mechanisms of protection may be involved.
Key Words: ischemia • lasers • revascularization • capillaries • collateral circulation • remodeling
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
The possibility of restoring adequate coronary blood flow and relieving ischemia in patients with coronary artery disease via channels made directly through the myocardium from the epicardial surface to the ventricular lumen is being examined currently in clinical trials.1 2 3 Such a technique would be particularly useful in patients who are unable to undergo angioplasty or bypass graft surgery, in cases in which previous surgery has failed, or in patients with intractable angina.4 However, it is unclear from published animal studies how, or even if, such channels can provide blood flow to ischemic tissue. The published animal experiments have tested the ability of channels to supply blood to ischemic tissue by occluding the vessel that would normally supply that tissue.5 6 7 8 There are two problems associated with these experiments: (1) the channels were made either just before or just after the coronary artery occlusion, which means that to be effective, the channels would have to supply blood immediately to the ischemic tissue; and (2) most of the studies examined the effects of channels made in dog hearts,5 6 7 8 a model known to possess variable collateral perfusion, yet failed to measure collateral blood flow. Although there is considerable evidence that the channels cannot immediately supply blood flow,9 10 11 there is anecdotal evidence that transmural channels improve cardiac perfusion in patients.3 12 13 To reconcile this apparent paradox, our hypothesis was that making channels might, over time, stimulate a protective effect, possibly by the growth of new vessels that could connect the ventricular lumen to the existing circulation via the channels. Such a stimulatory process would not occur immediately; therefore, we chose to make the channels 2 months before a coronary artery occlusion was induced to challenge any protective system that might have developed. If the channels could supply blood to ischemic tissue, then we would expect to see smaller infarcts in treated than in nontreated hearts. We made the channels in rat hearts, which have little or no native collateral circulation. Although most recent studies have made channels by use of laser energy, earlier experiments used biopsy or hypodermic syringe needles.14 15 16 17 Thus, in our experiment, we sought to examine the efficacy of both needle- and laser-made channels.
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
The protocol was approved by the Hospital's Animal Care and Use Committee and conforms to the principles of the American Physiological Society. The Heart Institute, Good Samaritan Hospital is accredited by the American Association for Accreditation of Laboratory Animal Care.
Channel Surgery
Ninety-three female, retired-breeder,
Sprague-Dawley rats (body mass range, 305 to 505 g) were
entered into the study. The rats were anesthetized with
ketamine (100 mg/kg) and xylazine (40 mg/kg) given
intramuscularly, intubated, and ventilated with room air. A thoracotomy
was performed through the fifth intercostal space to expose the apical
region of the heart, and the parietal pericardium was removed. At this
point, we randomized the rats to one of three groups: laser treatment,
needle treatment, or control.
In the laser-treated rats, we made six channels from the epicardial surface to the ventricular lumen in the anterior left ventricular wall, which is the region of the heart that becomes ischemic when the left coronary artery is occluded. We avoided regions in which surface vessels could be seen and tried to space the channels evenly, at least 3 mm apart. We used a flash-lamp pulsed holmium:yttrium-aluminum-garnet (YAG) laser (Laser 1-2-3, Schwarz Electro-Optics), which produced multimode radiation at a wavelength of 2.1 µm and a pulse width of 250 µs. The laser beam was focused into a flat-tipped, 400-µm-diameter optic fiber. The output power at the tip was 200 mJ per pulse, and the repetition rate was 2 Hz. We wanted to produce the channels by tissue ablation and not by pushing the optic fiber through the heart, so only slight pressure was applied to keep the fiber tip in contact with the tissue. Less than six pulses were required to cross the wall. Passage into the ventricular cavity was marked by a loss of resistance to the applied pressure and by pulsatile bleeding when the fiber was withdrawn. The bleeding was stopped by application of pressure via a cotton-tipped swab for a few minutes, and the chest was closed.
In the needle-treated group, the six channels were made in the same location as described above but by use of a 25-gauge hypodermic needle with an external diameter of 400 µm. Passage of the needle into the ventricular lumen was indicated by a pulsatile flow of blood into the body of the needle. There was more bleeding associated with needle-made than with laser-made channels; however, the bleeding appeared to stop as before when pressure was applied with a cotton-tipped swab.
In the control group, there was no intervention, but the chest was left open for a similar duration as for the other groups (approximately 20 minutes).
After the rats regained consciousness, they were returned to their cages. Two months later, the rats were reanesthetized and randomized to undergo either (1) coronary artery occlusion and subsequent histological analysis of myocardial morphology or (2) analysis of capillary density.
Coronary Artery Occlusion
After the rats were anesthetized
with ketamine
and xylazine (doses given above), we performed a tracheostomy and
ventilated the lungs with room air. Additional anesthetic was given as
required throughout the protocol. A catheter was placed in the left
femoral artery to measure blood pressure. A thoracotomy was performed
via the fourth intercostal space, and the basal region of the heart was
exposed. We placed a stitch using a C-1 taper needle and 5-0
polypropylene suture from the atrioventricular groove
to the pulmonary cone. Additional sutures were tied to each arm
of the stitch suture to enable the occlusion knot to be
untied.18 We then tied a single knot in the stitch suture
to occlude the coronary artery. Occlusion of the artery was
confirmed by an increase in amplitude of the ECG signal and development
of a deep S wave within the first minute after occlusion. At 90 minutes
after occlusion, the artery was reperfused by pulling the releaser
sutures to untie the occlusion knot. The artery was reperfused for 4.5
hours. Heart rate and mean arterial blood pressure were
recorded before occlusion, 5 minutes after occlusion, and at the
end of the experiment. At the end of the experiment, the artery was
briefly reoccluded, and 0.5 mL of blue pigment (Unisperse Blue,
Ciba-Geigy Corporation) was injected into the circulation via the left
femoral vein to delineate the tissue perfused by the occluded vessel.
The nonperfused tissue is referred to as the area at risk of
infarction. The heart was arrested in diastole by injection
of 3 mL of a saturated potassium chloride solution while the animal was
under deep anesthesia. The heart was then cut into four or
five slices parallel to the atrioventricular groove and
photographed. To assess the amount of muscle necrosis, heart slices
were incubated for 15 minutes in a 1% solution of
triphenyltetrazolium chloride (TTC) at
37°C and rephotographed. TTC stains viable muscle red, whereas
necrotic muscle does not stain and so appears
pale.19 20
We used computer-assisted planimetry to determine the size of the
area at risk (expressed as a percent of the area of the left ventricle)
and the size of the area of necrosis (expressed as a percent of both
the left ventricle and the area at risk) as described
previously.21
Histology
To assess the effect of channel making on
myocardial structure,
we measured four parameters: (1) fibrosis associated with
the channels, (2) myocyte orientation, (3) myocardial collagen content
in tissue remote from the channels, and (4) capillary density in the
myocardium. In addition, we examined the tissue for the
presence of blue pigment in and around the channels and for vascular
connections to the channels. This analysis was performed on the
hearts used in the infarct-size study, except for analysis
of capillary density, which was performed on an additional set of 17
hearts that were randomized to this part of the study 2 months after
the channels were made. For analysis of the first three
structural parameters, heart slices were fixed in a
solution of 10% neutral buffered formalin, processed for paraffin
embedding, and sectioned perpendicular to the apex-base axis at a
thickness of 5 µm. The sections were stained with hematoxylin and
eosin and with picrosirius red.22
Channel-Associated
Fibrosis
We measured the maximum width of fibrosis associated with the
channels from bright-field examination of picrosirius
red–stained sections using a x10 objective lens and a calibrated
eyepiece graticule. The red-stained collagen is easily
differentiated from the yellow-stained muscle.
Myocyte
Organization
We previously found that viable muscle adjacent to healed
infarcts no longer possessed the normal highly aligned parallel
organization.23 We therefore sought to determine if a
similar disruption occurred adjacent to fibrosis associated with the
channels. We measured the two-dimensional orientation of 50
longitudinally sectioned, picrosirius red–stained myocytes
adjacent to channel-associated fibrosis in both treated groups and
also from comparable locations in the control group. Measurements were
made according to previously published methods by use of a polarized
light microscope equipped with a rotating stage.23 24
A
x40 objective lens was used. In two hearts from both the laser- and
needle-treated groups, we were unable to locate regions of
longitudinally sectioned muscle, and these four hearts were excluded
from this analysis. We used circular statistics to calculate
the angular deviation of each measured distribution (the circular
statistics equivalent of standard deviation) and then calculated the
average angular deviation for the muscle orientation distributions
obtained in each group.
Collagen Content
It is
known that the presence of a myocardial infarct results in
an increase in the collagen content of noninfarcted
tissue.25 We speculated that the focal muscle necrosis
caused by making the channels might result in similar changes.
Therefore, we measured myocardial collagen content in the left
ventricular free wall in areas remote from the channels and
also in the interventricular septum. Collagen content
was measured from picrosirius red–stained sections examined by use
of a video image analysis subtraction method described
previously.26 In each heart, three separate areas were
analyzed (each 0.33x0.24 mm) in both the left
ventricular free wall and the
interventricular septum by use of a x20 objective
lens. We then calculated average collagen content expressed as a
percent of total area and average collagen content in each of the
groups in each of the areas examined.
Capillary Density
Analysis
After fixation by immersion in a 10% solution of neutral
buffered formalin, the hearts used in this analysis were
dehydrated in alcohol, embedded in historesin, sectioned at a thickness
of 1 µm, and stained by Avallone's modification of Jones'
silver
methenamine method for staining basement membranes.27
Previous study has shown that the capillary densities calculated from
immersion-fixed hearts do not differ from those obtained from
hearts fixed by perfusion with
glutaraldehyde.28 Photomicrographs were
taken of myocytes cut approximately in cross section in three areas of
subendocardial tissue: (1) adjacent to scar tissue associated with the
channels, (2) in the left ventricular free wall remote from
scar tissue, and (3) in the interventricular septum.
The average density of capillaries and myocytes and the
capillary-myocyte density ratio was calculated for each region as
previously described.27
Statistics
We used ANOVA to test for differences between the
three groups.
Subsequent comparisons were made by use of Tukey's test. Mortality was
evaluated using a 
2 test. Values were expressed
as mean±SEM and were considered to be significantly different if the
probability was less than .05. Analysis of myocyte orientation
was performed by use of circular statistics.29
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Mortality
Table 1
shows the mortality
associated with both
the initial surgery and the coronary artery occlusion. Although
both lasers and needles caused ectopic beats when the channels were
made, these arrhythmias were not responsible for any deaths.
The needle-treated group had the highest initial mortality (57%;
P<.05 versus control).
|
Mean time between the original
surgery and coronary artery
occlusion was 64 days in each group (range, 62 to 68 days). The number
of rats that died after occlusion was four in the control group, none
in the needle-treated group, and three in the laser-treated
group. The hearts of two of the laser-treated rats that died
contained healed scars. Presumably these scars were the result of a
channel perforating or occluding a coronary artery during the
initial surgery. One of these scars was large, occupying approximately
40% of the circumference of the left ventricle. This heart was
excluded from all further analysis. The second heart contained
a small apical scar and was transferred to the capillary density
analysis group. The four control rats that died during
occlusion were also transferred to the capillary analysis
group; however, good-quality sections were obtained from only one
of these hearts. The other three were excluded from further
analysis. The number of rats analyzed in each group and
the number of exclusions are shown in Table 2.
|
Hemodynamics
There were no differences in either heart rate
or mean
arterial blood pressure between the three groups at any of
the time points examined (Table 3).
|
Area at Risk
The margins of the area at risk of infarction
were defined as the
lateral borders of the areas of the heart slices stained deep blue by
in vivo pigment injection. It is possible that the presence of the
channels could have reduced the size of the area at risk; however,
there was no statistically significant difference between the groups
(control, 60±3%; needle-treated group, 51±5%; laser-treated
group, 53±7%; expressed as percent of the left ventricle).
Infarct Size
The area of necrosis, expressed as percent of
the left ventricle,
was significantly smaller in the needle-treated group than in the
controls (15±6% versus 40±3%, P<.01). Necrosis in
laser-treated hearts (27±5%) was not significantly different from
the other groups (Fig 1). However, there was evidence of
localized myocardial salvage adjacent to channels in all eight
laser-treated hearts.
|
Because a reduction in necrosis expressed as a percent of the left ventricle could be achieved simply by a more distal occlusion of the artery rather than by a treatment effect, it is usual to express the amount of necrosis as a percent of the area at risk (AN/AR). However, because the channels could have reduced the size of the area at risk, such calculation might not provide a true reflection of infarct size. For example, this calculation might mask a protective effect (if area at risk is reduced, then AN/AR will be larger than it should be); however, it would not give a false-positive result. Infarct size, expressed as a percent of the area at risk, was smaller in needle-treated hearts than in the control group (28±9% versus 68±6%, P<.01). Infarct size in the laser-treated hearts (46±7%) was not significantly different from the other groups. Therefore, the reduction in necrosis found in the needle-treated hearts appears to be a treatment effect and not a function of a more distal occlusion.
Evidence for Flow via Channels
Although there was no
quantitative difference in area at risk
between the groups, macroscopic inspection of the tissue slices
revealed qualitative differences in pigment perfusion within the risk
region. In control hearts, we observed the expected sharp boundary
between the perfused and nonperfused regions. In contrast, the area at
risk in some of the needle-treated hearts had a blue tinge. In one
of the slices from a control heart, we observed a blue-stained
region in the subepicardial muscle within the lateral boundaries of the
area at risk that did not become necrotic. The heart had adhered to the
chest wall at this location, and we speculate that new blood vessels
grew into the subepicardial tissue from the chest wall. We also
observed pale blue regions within the area at risk in some of the
laser-treated hearts. These macroscopic observations were confirmed
by microscopic analysis. Fig 2A shows a
high-magnification view of a channel from a needle-treated
heart. A bifurcating vessel containing red blood cells and blue pigment
can be seen within the scar tissue. Pigment can also be seen in the
surrounding tissue. We observed vessels connected to the channels; for
example, Fig 2B shows a vessel aligned perpendicular to a
needle-made channel that contains both red blood cells and pigment.
The channels were all smaller than the 400-µm-diameter optic
fiber or needle used to create them (Figs 2B and
3A). In
fact, some of the laser-made channels appeared to be completely
occluded by fibrosis (Fig 3B).
|
|
Channel-Associated Fibrosis
We were able to locate 45 of the
96 channels made in
histological sections. Of these, 25 were from
laser-treated hearts and 20 were from needle-treated hearts. At
least one measurement of fibrosis was made from each heart. The average
width of fibrosis was significantly greater in the laser-treated
hearts (430±50 versus 180±30 µm in needle-treated hearts,
P<.0001 by use of Mann-Whitney test, based on the total
number of channels examined). Fig 3
shows
representative examples of channel-associated
fibrosis in needle- and laser-treated hearts, and Fig 4 shows
the distribution of channel-associated
fibrosis with both treatments. The maximum width of fibrosis
associated with the majority of channels was in the 200- to 400-µm
range; however, only channels created by needles had <200 µm of
fibrosis, and only laser-created channels had >600 µm.
|
Myocyte Orientation
In control hearts, myocytes exhibited the
expected parallel
alignment (Fig 5), resulting in orientation
distributions with small angular deviations. In contrast, myocytes
adjacent to laser-made channels were no longer aligned in parallel;
thus, the orientation distributions were broadened, and the angular
deviations of the distributions were higher (Fig 6). The
mean angular deviation in the laser-treated group was 9.4±0.7°,
which was greater than in the control group (5.0±0.3°,
P<.01). The mean in the needle-treated group was
6.9±1.1°, which did not differ from either the control or
laser-treated group. Thus, normal organization of myocytes was
disrupted by the presence of the channels, and the degree of disruption
was greatest in laser-treated hearts.
|
|
Collagen Content
Collagen content in the left ventricular
free wall (in
tissue away from the channels) was significantly greater in
laser-treated hearts (3.6±0.3%) than in either control hearts
(2.5±0.2%, P<.05) or needle-treated hearts
(2.5±0.3%, P<.05). However, there was no difference in
collagen content measured in the interventricular
septum between the groups (control, 2.3±0.3%; needle-treated
hearts, 2.7±0.2%; laser-treated hearts, 2.8±0.2%). Thus, laser
treatment resulted in a significant increase in
interstitial fibrosis in the left ventricular
free wall away from the channels; however, the increase did not extend
into the interventricular septum.
Capillary Density
There was no difference between average
capillary densities in
each group in each of the regions examined (Table 4).
The calculated values of capillary density are similar to those
reported for 9-month-old rats,30 which was the
approximate age of animals in the present study. Similarly, there
was no difference in myocyte density between groups (Table 4),
and
hence capillary-myocyte ratios were unchanged by channel
making.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
We found that the presence of transmural myocardial channels protected the heart against coronary artery occlusion applied 2 months later. Channels made with a needle provided greater protection than those made with use of a holmium:YAG laser. Infarct size was reduced by an average of >50% in needle-treated hearts, and four of the infarcts occupied <10% of the area at risk. We also observed muscle protection adjacent to channels in all eight laser-treated hearts. This localized protection was insufficient to give a statistically significant reduction in infarct size; however, its location and consistency are compatible with channel-related protection.
Mechanism of Protection
The protection against cell death
that we observed is related, in
general terms, to oxygen supply and demand. Either oxygen supply was
increased or oxygen demand was decreased. There were no differences in
heart rate and blood pressure between groups, so these
hemodynamic factors can be eliminated as potential
explanations for the decrease in infarct size.
One possible explanation for increased oxygen supply is that blood was able to flow from the ventricular cavity to the ischemic tissue via the channels. Although we do not have a direct measurement of blood flow, there was indirect evidence consistent with flow via the channels. There was evidence in both laser-treated and needle-treated hearts that small amounts of pigment were able to enter at least some of the area at risk, rendering the region pale blue. Histological examination supported the idea that some pigment gained access to the ischemic tissue via the channels. Pigment could be seen in fibrosis associated with the channels and in surrounding myocardium. Because the rat heart has little or no native collateral circulation, the pigment most likely entered the area at risk via the channels.
How did the blood and pigment gain access to the
area at risk via the
channels? Our original hypothesis was that the channel-making
process might stimulate the growth of new vessels. However, there was
no overall increase in capillary density (Table 4).
Measurements were
made over a relatively large area, and so we cannot exclude the
possibility that capillary growth was confined to localized regions,
nor can we exclude the possibility that there was an increase in
larger-diameter vessels, such as arterioles. With a capillary
density in the rat hearts >2000/mm2 (the same density
found in adult human hearts28 ), it is inevitable that a
considerable number of capillaries would have been intersected when the
channels were made. However, such intersections do not appear to allow
immediate blood flow to the tissue, as demonstrated by the failure of
laser-created channels to provide protection against acute
ischemia. Therefore, to explain a later increase in blood flow,
either new vessels grew in the scar tissue around the channels, or
vessels sprouted from the damaged ends of the transected capillaries
and connected to the channel lumens. We observed vessels containing
pigment and red blood cells that had direct connections with the
channels (Fig 2B). The diameter of these vessels ranged from 2
to 10
µm, which is comparable to the range of capillary diameters in rat
hearts measured from corrosion casts.31 We also noted
pigment in the subepicardial tissue of a control heart at the site of
adhesion to the chest wall. Both channel making and adhesion elicit a
wound-healing response, a known stimulus for vessel
growth.32
We found structural changes in hearts containing channels that might be compatible with decreased oxygen demand. Muscle cells in the immediate vicinity of channel-associated fibrosis lacked the normal parallel organization found in control hearts. Such disorganization is likely to impair contractile function and could result in areas of hypokinesis adjacent to the channels. This situation may be similar to the disorganization of contractile elements found after unloading cardiac papillary muscle by cutting chordae tendineae.33 Cardiac unloading produces a rapid and severe loss of contractile function and may result in metabolic downregulation and a resultant reduction in oxygen demand.34 Similar metabolic downregulation of disorganized muscle adjacent to the channels might enable it to survive coronary artery occlusion. In addition, oxygen could be supplied via diffusion from a patent channel even if there was no blood flow directly to the tissue. The protection afforded by such downregulation with or without oxygen diffusion would be limited by the extent of downregulation and by the limit of passive diffusion. Such a mechanism of protection would not be consistent with the significant reduction in infarct size found in the needle-treated hearts but would be consistent with the bands of viable muscle observed next to some of the laser-created channels.
There is a third possible protective mechanism that is worth considering: the tissue had an increased tolerance to ischemia. Several studies have demonstrated that stress—for example, in the form of increased temperature—can stimulate the production of endogenous protective agents called heat shock proteins.35 Whether heat shock proteins or other protective substances are produced in response to the channel-making process is unknown, as is the potential for such agents to provide protection 2 months after application of the stress.
In hearts that possessed little or no collateral blood flow, the finding of pigment within the area at risk is suggestive of a direct link, via the channels, between the ventricular cavity and the tissue. Nevertheless, additional studies will be required to determine the exact contribution of these proposed mechanisms to the observed reduction in infarct size.
Comparison of Needle- and Laser-Made Channels
The obvious
physical difference between the two channel-making
methods is that needle channels are made mechanically, whereas laser
channels are associated with a thermal process. The influence of
thermal injury on channel patency is unclear. Owen et al36
examined the temporal response of rat myocardium to the
presence of channels made by use of a carbon dioxide laser and found
that thermal injury produced an `intense inflammatory response,'
which they concluded was inconsistent with provision of an
alternative circulation. Hardy et al37 examined channels
made in dog hearts by use of either a carbon dioxide laser or an
18-gauge hypodermic syringe needle. The authors stated that
needle-made channels were completely occluded within 2 days by
cellular infiltrate, which was eventually replaced by scar
tissue.37 Laser-created channels remained patent
slightly longer before they too were occluded, first by fibroblasts and
macrophages and subsequently by collagen. The
authors37 speculated that thermal injury to
myocardium adjacent to the channels delayed healing and
thus maintained channel patency, albeit briefly. In the present
study (2 months after the channels were made), we found that channels
were 40 µm wide at most and that some of the laser-made channels
did not appear to be patent. However, the lack of an obvious channel in
histological sections does not preclude blood flow in
vivo via the channels. Thus, the challenge of coronary artery
occlusion and injection of pigment are useful additional tests of the
functional ability of the channels.
In a pilot experiment, we found
that the laser provided no protection
against later ischemia.38 However, we have shown
that it is possible to alter the degree of thermal injury associated
with the holmium:YAG laser by changing pulse energy or repetition
rate.39 We therefore performed an in vitro study to
determine the appropriate parameters to minimize thermal
injury and yet permit rapid passage through the ventricular
wall. We found that the combination of 200 mJ per pulse and a
repetition rate of 2 Hz was the best combination (in the pilot
experiment, we used 200 mJ and 3 Hz). We assume it was this reduction
of thermal injury that improved the results obtained with the laser.
The extent of tissue damage associated with creation of the channels
should be reflected in the amount of fibrosis produced. Even though we
reduced the amount of thermal injury in the current study, the presence
of fibrosis indicated that tissue damage still occurred. The maximum
width of fibrosis associated with laser-created channels was much
greater than for needle-made channels (Figs 3 and
4). We speculate
that further reduction of thermal injury, and hence fibrosis, may
improve results in laser-treated hearts. Moreover, we propose that
needle-created channels provided more protection in our experiments
because they caused less damage to surrounding tissue than the
relatively extensive thermal injury associated with the holmium:YAG
laser. Another potential cause of tissue injury is the
production of vapor bubbles by pulsed holmium
lasers.40 We found that the degree of myocardial
disruption by such `acoustic' injury was slight at repetition
rates
of 2 and 3 Hz, especially at the pulse energies used in the current
study.39 Nevertheless, vapor bubbles may be responsible
for tissue injury in excess of that caused by temperature
increases.
We found that the process of making channels exerted effects beyond the tissue that was initially injured. Fibrosis associated with the initial injury resulted in disorganization of adjacent myocytes. The observed disarray is similar to that found in viable muscle adjacent to a healed infarct.23 The degree of muscle disorganization may be determined by the amount of channel-associated fibrosis, because more disarray was found in laser-treated than in needle-treated hearts. Furthermore, we found an increase in the amount of interstitial fibrosis in tissue distant from the channels in laser-treated hearts. There are at least two possible explanations for this observation. After myocardial infarction, there is an increase in the amount of fibrosis in noninfarcted tissue,25 and a similar process may occur after the focal necrosis caused by making the channel. Second, because the increase in distant, interstitial fibrosis was found only in laser-treated hearts, it could be a direct stimulatory effect of the laser itself.
The structural changes that we observed in laser-treated hearts could have deleterious effects. For example, muscle disarray could result in diminished function and could also provide a substrate for abnormal electrical conduction and hence increase the potential for the development of arrhythmias. Similarly, the increase in interstitial collagen could also be expected to affect function by making the heart stiffer and could affect electrical conduction by decreasing the amount of cell-to-cell contact. These effects on distant tissue emphasize the need for further investigation of the methods used to create the channels.
Previous Experiments
Animal Studies
It is
difficult to interpret many of the previous experiments in
which transmural channels were examined because they failed to measure
native collateral blood flow. Before blood flow via the channels can be
confirmed, it is necessary to take into account collateral blood flow
from other coronary artery beds into the area served by the
occluded artery, either by measuring collateral blood flow or by using
an animal that has little or no collateral flow. Most previous studies
have tested channels in dog hearts, which can have variable native
collateral circulations. Therefore, it is impossible to know if any
beneficial effect was attributable to the channels or if the treated
hearts had high intrinsic collateral flow. Such limitations also apply
to sheep41 and, to a lesser extent, to rabbit
hearts.42 In contrast, pig and rat hearts have little
native collateral circulation.
A second confounding factor in many previous studies is the temporal relation between creation of the channels and coronary artery occlusion. In most of the studies, the channels were made either just before or just after coronary occlusion. To obtain a positive effect, the channels would have to provide an immediate increase in tissue blood flow. There is substantial evidence that laser-made channels cannot provide immediate blood flow to ischemic myocardium, either in dog hearts (when collateral flow was measured)9 10 11 or in pig hearts.43 44 The evidence against acute benefit from the laser channels rules out the possibility of blood flow via the myocardial sinusoids, as proposed by those who claim that blood can circulate immediately via the channels.3 The only other study that tested needle-made channels several weeks before coronary occlusion was performed in dogs and did not measure collateral flow.17 Thus, our study is, to our knowledge, the first to examine an ischemic challenge to transmural channels several weeks after the channels were made in a model in which preexisting collateral circulation was not a factor.
Clinical Studies
The concept of supplying blood to ischemic tissue via
alternative channels has historical precedent. Creating channels is in
some respects similar to the Vineberg procedure, in which the internal
mammary artery was tunneled directly into the myocardium.
Although the operation was controversial, there was evidence that the
Vineberg procedure worked by stimulating the growth of new vessels
connecting the arterial insertion with the existing
circulation.45 Recent studies used radioactive
microspheres to document flow via the internal mammary artery
in dogs 8 weeks after implantation of the vessel into the
myocardium46 and found that the flow could be
increased by heparin treatment,47 an agent known to play
an indirect role in vascular neogenesis.
Although clinical trials designed to evaluate channels made by use of a carbon dioxide laser are in progress, only limited data has been published. The reports claim that patients examined several months after the channels were made had increased myocardial perfusion and less angina.1 2 3 Gradual rather than immediate improvement would be consistent with new vessel growth in response to the channel-making process. Mirhoseini et al13 reported endothelialization of laser-made channels and an increase in the number of vessels in treated myocardium from a patient who died 4 years after the original channels were made. However, it was not clear whether the increase in vessels was because of angiogenesis or the presence of numerous laser-made channels. More recently, Cooley et al48 described the histology of channels made by use of a carbon dioxide laser in a patient who died 3 months later. Vascular connections were observed between the channels and native myocardial vessels. In addition, each channel was surrounded by fibrosis (width, 150 to 500 µm) and the channel diameter (20 to 75 µm) was less than the initial diameter of 1 mm. Both the presence of channel-associated fibrosis and a reduction of channel diameter over time are similar to our results.
Study Limitations
The main limitation of the present study is
that we did not
document an increase in blood flow via the channels. Although our
evidence of reduced infarct size and the observation of pigment within
the area at risk is consistent with flow via the channels, it
is circumstantial rather than conclusive evidence.
Although we demonstrated that the presence of transmural channels protected the myocardium against later ischemia, the model used—a normal, healthy heart—may not be relevant. In a practical situation, channels would be made through tissue with a compromised blood supply. We do not know if such tissue would respond differently.
We examined only one type of laser. We did so because the reported mechanism of protection (an immediate increase in blood flow via myocardial sinusoids) did not appear to depend on the method of creating the channels. However, we interpret our results to indicate that the method of making the channels is a crucial determinant of success. We speculate that if reduction of thermal injury is important, then it is likely that different lasers or different methods of energy delivery (for example, use of a Q-switch to produce short, powerful energy pulses) will give better results than obtained with the holmium laser we used.
In the present study, creation of channels was associated with high mortality, perhaps because of perforation of coronary arteries resulting in myocardial ischemia. This possibility was supported by the observation of healed scars in two laser-treated hearts. We did not perform necropsies on animals that died, and thus we cannot rule out either pneumothorax or hemothorax as a cause of death. In addition, we cannot exclude the possibility that the high initial mortality after needle treatment might have resulted in a group that was in some way better able to withstand ischemia.
The size of rat hearts limits the number and diameter of channels that reasonably can be made. It is possible that the diameter and density we used was not optimal. It is evident that after 2 months, the diameter of the channels was less than the 400-µm-diameter needle or optic fiber used to create them. Healing of the initial injury may be responsible for this reduction in channel diameter, and it is possible that channels with larger initial diameters may maintain greater patency after the healing process is complete.
Summary
Channels made through the myocardium were able to
protect the heart against coronary occlusion 2 months later. In
our experiments, needle-made channels provided greater protection
than channels made with a holmium:YAG laser. The precise mechanism of
protection remains unknown, although the results of our study are
consistent with the concept that channels are able to provide
blood flow to the tissue from the ventricular cavity. Our
study provides some support and rationale for the clinical trials that
are currently under way to test the value of laser-made channels in
patients. However, our results emphasize that the mechanism of
protection is unclear, and therefore we do not know the best method of
making the channels.
|
Acknowledgments |
|---|
This study was supported in part by a grant (to K.R.) from the Heart and Stroke Foundation of Ontario. We thank Seda Dzhandzhapanyan and Barbara Hébert for assistance with the histology, Shi-ming Zheng for advice regarding laser operation, and Karin Przyklenk for editorial assistance.
|
Footnotes |
|---|
Reprint requests to Peter Whittaker, PhD, Heart Institute, Good Samaritan Hospital, 1225 Wilshire Blvd, Los Angeles, CA 90017.
Received August 5, 1994; revision received July 10, 1995; accepted August 8, 1995.
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
1. Crew JR, Thuener M, Jones R, Ryan C, Chimenti C, Fisher JC. Transmyocardial revascularization. J Am Coll Cardiol. 1994;23(suppl):151A. Abstract.
2. Mirhoseini M, Cayton MM, Shelgikar S. Transmyocardial laser revascularization. J Am Coll Cardiol. 1994;23(suppl):416A. Abstract.
3. Mirhoseini M, Shelgikar S, Cayton MM. Transmyocardial laser revascularization: a review. J Clin Laser Med Surg. 1993;11:15-19. [Medline] [Order article via Infotrieve]
4.
Mulcahy D, Knight C, Stables R, Fox K. Lasers,
burns, cuts, tingles and pumps: a consideration of alternative
treatments for intractable angina. Br Heart J. 1994;71:406-407.
5. Mirhoseini M, Cayton MM. Revascularization of the heart by laser. J Microsurg. 1981;2:253-260. [Medline] [Order article via Infotrieve]
6. Jeevanandam V, Auteri JS, Oz MC, Watkins J, Rose EA, Smith CR. Myocardial revascularization by laser-induced channels. Surg Forum. 1990;41:225-227.
7. Yano OJ, Bielefeld MR, Jeevanandam V, Treat MR, Marboe CC, Spotnitz HM, Smith CR. Prevention of acute regional ischemia with endocardial laser channels. Ann Thorac Surg. 1993;56:46-53. [Abstract]
8. Okada M, Shimizu K, Ikuta H, Horii H, Nakamura K. A new method of myocardial revascularization by laser. Thorac Cardiovasc Surg. 1992;39:1-4.
9. Whittaker P, Kloner RA, Przyklenk K. Laser-mediated transmural myocardial channels do not salvage acutely ischemic myocardium. J Am Coll Cardiol. 1993;22:302-309. [Abstract]
10. Hardy RI, James FW, Millard RW, Kaplan S. Regional myocardial blood flow and cardiac mechanics in dogs with CO2 laser-induced intramyocardial revascularization. Basic Res Cardiol. 1990;85:179-197. [Medline] [Order article via Infotrieve]
11. Landreneau R, Nawarawong W, Laughlin H, Ripperger J, Brown O, McDaniel W, McKown D, Curtis J. Direct CO2 laser `revascularization' of the myocardium. Lasers Surg Med. 1991;11:35-42. [Medline] [Order article via Infotrieve]
12. Okada M, Ikuta H, Shimizu K, Horii H, Nakamura K. Alternative methods of myocardial revascularization by laser: experimental and clinical study. Kobe J Med Sci. 1986;32:151-161. [Medline] [Order article via Infotrieve]
13. Mirhoseini M, Shelgikar S, Cayton M. Clinical and histologic evaluation of laser myocardial revascularization. J Clin Laser Med Surg. 1990;9:73-78.
14. Sen PK, Udwadia TE, Kinare SG, Parulkar GB. Transmyocardial acupuncture: a new approach to myocardial revascularization. J Thorac Cardiovasc Surg. 1965;50:181-189.
15. Sen PK, Daulatram J, Kinare SG, Udwadia TE, Parulkar GB. Further studies in multiple transmyocardial acupuncture as a method of myocardial revascularization. Surgery. 1968;64:861-870. [Medline] [Order article via Infotrieve]
16. White M, Hershey JE. Multiple transmyocardial puncture revascularization in refractory ventricular fibrillation due to myocardial ischemia. Ann Thorac Surg. 1968;6:557-563. [Medline] [Order article via Infotrieve]
17. Khazei AH, Kime WP, Papadopoulos C, Cowley RA. Myocardial canalization: a new method of myocardial revascularization. Ann Thorac Surg. 1968;6:163-171. [Medline] [Order article via Infotrieve]
18.
Himori N, Matsuura A. A simple technique for
occlusion and reperfusion of coronary artery in conscious
rats. Am J Physiol. 1989;256:H1719-H1725.
19. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101:593-600. [Medline] [Order article via Infotrieve]
20. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol. 1985;121:522-530. [Abstract]
21. Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J. 1992;123:346-353. [Medline] [Order article via Infotrieve]
22. Sweat F, Puchtler H, Rosenthal SI. Sirius red F3BA as a stain for connective tissue. Arch Pathol. 1964;78:69-72. [Medline] [Order article via Infotrieve]
23. Whittaker P, Boughner DR, Kloner RA. Analysis of healing after myocardial infarction using polarized light microscopy. Am J Pathol. 1989;134:879-893. [Abstract]
24. Whittaker P, Canham PB. Demonstration of quantitative fabric analysis of tendon collagen using two-dimensional polarized light microscopy. Matrix. 1991;11:56-62. [Medline] [Order article via Infotrieve]
25. Volders PGA, Willems IEMG, Cleutjens JPM, Arends JW, Havenith MG, Daemen MJAP. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol. 1993;25:1317-1323. [Medline] [Order article via Infotrieve]
26. Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial collagen content with picrosirius red staining and circularly polarized light. Basic Res Cardiol. 1994;89:397-410. [Medline] [Order article via Infotrieve]
27.
Rakusan K, Turek Z. Protamine inhibits capillary
formation in growing rat hearts. Circ Res. 1985;57:393-398.
28.
Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh
R. Morphometry of human coronary capillaries during
normal growth and the effect of age in left ventricular
pressure-overload hypertrophy.
Circulation. 1992;86:38-46.
29. Batschelet E. Circular Statistics in Biology. London, UK: Academic Press; 1981.
30.
Rakusan K, Sarkar K, Turek Z, Wicker P. Mast
cells in the rat heart during normal growth and in cardiac
hypertrophy. Circ Res. 1990;66:511-516.
31. Potter RF, Groom AC. Capillary diameter and geometry in cardiac and skeletal muscle studies by means of corrosion casts. Microvasc Res. 1983;25:68-84. [Medline] [Order article via Infotrieve]
32. Leibovich SJ, Wiseman DM. Macrophages, wound repair and angiogenesis. In: Barul A, Pines E, Caldwell M, Hunt TK, eds. Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications. New York, NY: Alan R Liss, Inc; 1988:131-145.
33.
Cooper G, Tomanek RJ. Load regulation of the
structure, composition, and function of mammalian
myocardium. Circ Res. 1982;50:788-798.
34. Marshall RC. Correlation of contractile dysfunction with oxidative energy production and tissue high energy phosphate stores during partial coronary flow disruption in rabbit hearts. J Clin Invest. 1988;82:86-95.
35. Knowlton AA. The role of heart shock proteins in the heart. J Mol Cell Cardiol. 1995;27:121-131. [Medline] [Order article via Infotrieve]
36. Owen ER, Canfield P, Bryant K, Hopwood PR. Observations on the effects of CO2-laser on rat myocardium. Microsurgery. 1984;5:140-143. [Medline] [Order article via Infotrieve]
37. Hardy RI, Bove KE, James FW, Kaplan S, Goldman L. A histologic study of laser-induced transmyocardial channels. Lasers Surg Med. 1987;6:563-573. [Medline] [Order article via Infotrieve]
38. Whittaker P, Zheng S, Kloner RA. Chronic response to direct myocardial revascularization: a preliminary study. In: Abela GS, ed. Diagnostic and Therapeutic Cardiovascular Interventions III. Bellingham, Wash: SPIE; 1993:160-166. Publication no. SPIE 1878.
39. Zheng S, Kloner RA, Whittaker P. Ablation and coagulation of myocardial tissue by means of a pulsed holmium:YAG laser. Am Heart J. 1993;126:1474-1477. [Medline] [Order article via Infotrieve]
40. van Erven L, van Leeuwen TG, Post MJ, van der Veen MJ, Velema E, Borst C. Mid-infrared pulsed laser ablation of the arterial wall: mechanical origin of `acoustic' wall damage and its effect on wall healing. J Thorac Cardiovasc Surg. 1992;104:1053-1059. [Abstract]
41. Rezkalla S, Turi ZG, Keedy D, Precevski P, Kloner RA. Left main coronary angioplasty in a sheep model using a new left main autoperfusion balloon catheter. J Invest Cardiol. 1989;1:199-205.
42. Hale SL, Kloner RA. Effect of ischemic preconditioning on regional myocardial blood flow in the rabbit heart. Coron Artery Dis. 1992;3:133-140.
43. Goda T, Wierzbicki Z, Gaston A, Leandri J, Vouron J, Loisance D. Myocardial revascularization by CO2 laser. Eur Surg Res. 1987;19:113-117. [Medline] [Order article via Infotrieve]
44. Weng G, Williamson WA, Aretz HT, Schick EC, Labib SB, Shahian DM, Shapshay SM. The effect of holmium:YAG laser mediated transmyocardial channels on left ventricular contractility in an acute ischemic model. Lasers Surg Med. 1993;13(suppl 5):13. Abstract.
45. Vineberg AM. Myocardial Revascularization by Arterial/Ventricular Implants. Boston, Mass: John Wright PSG Inc; 1982.
46.
Unger EF, Sheffield CD, Epstein SE. Creation of
anastomoses between an extracardiac artery and the coronary
circulation: proof that myocardial angiogenesis occurs and can provide
nutritional blood flow to the myocardium.
Circulation. 1990;82:1449-1466.
47.
Unger EF, Sheffield CD, Epstein SE. Heparin
promotes the formation of extracardiac to coronary anastomoses
in a canine model. Am J Physiol. 1991;260:H1625-H1634.
48. Cooley DA, Frazier OH, Kadipasaoglu KA, Pehlivanoglu S, Shannon RL, Angelini P. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Tex Heart Inst J. 1994;21:220-224.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  P. Katrapati and J. C. George Vineberg Operation: A Review of the Birth and Impact of This Surgical Technique Ann. Thorac. Surg., November 1, 2008; 86(5): 1713 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text]
|
|
|
|
 |
|
 M. Nahrendorf, K.-H. Hiller, D. Theisen, K. Hu, C. Waller, R. Kaiser, A. Haase, G. Ertl, R. Brinkmann, and W. R. Bauer Effect of Transmyocardial Laser Revascularization on Myocardial Perfusion and Left Ventricular Remodeling after Myocardial Infarction in Rats Radiology, November 1, 2002; 225(2): 487 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert 35 years of experimental research in transmyocardial revascularization: what have we learned? Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Horvath, N. Belkind, I. Wu, R. Greene, J. Doukas, J. W. Lomasney, D. D. McPherson, and D. A. Fullerton Functional comparison of transmyocardial revascularization by mechanical and laser means Ann. Thorac. Surg., December 1, 2001; 72(6): 1997 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X M Mueller, H T Tevaearai, P Chaubert, C-Y Genton, and L K von Segesser Does laser injury induce a different neovascularisation pattern from mechanical or ischaemic injuries? Heart, June 1, 2001; 85(6): 697 - 701. [Abstract] [Full Text]
|
|
|
|
|
|
A. S. Bortone, D. D'Agostino, S. Schena, G. Rubini, P. Brindicci, V. Sardaro, A. D'Addabbo, and L. de Luca Tupputi Schinosa Inflammatory response and angiogenesis after percutaneous transmyocardial laser revascularization Ann. Thorac. Surg., September 1, 2000; 70(3): 1134 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Bridges Myocardial laser revascularization: the controversy and the data Ann. Thorac. Surg., February 1, 2000; 69(2): 655 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Whittaker Transmyocardial revascularization: the fate of myocardial channels Ann. Thorac. Surg., December 1, 1999; 68(6): 2376 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Rimoldi, S. M. Burns, S. D. Rosen, T. E. Wistow, P. M. Schofield, G. Taylor, and P. G. Camici Measurement of Myocardial Blood Flow With Positron Emission Tomography Before and After Transmyocardial Laser Revascularization Circulation, November 9, 1999; 100 (2009): II-134 - II-138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Chu, J.-q. Kuang, A. McGinn, A. Giaid, S. Korkola, and R. C. -J. Chiu ANGIOGENIC RESPONSE INDUCED BY MECHANICAL TRANSMYOCARDIAL REVASCULARIZATION J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 849 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]
|
|
|
|
|
|
B. G. Hattler, B. P. Griffith, M. A. Zenati, J. R. Crew, M. Mirhoseini, L. H. Cohn, S. F. Aranki, O.H. Frazier, D. A. Cooley, A. M. Lansing, et al. Transmyocardial laser revascularization in the patient with unmanageable unstable angina Ann. Thorac. Surg., October 1, 1999; 68(4): 1203 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. F. Chu, A. Giaid, J.-q. Kuang, A. N. McGinn, C. M. Li, M. P. Pelletier, and R. C.-J. Chiu Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures Ann. Thorac. Surg., August 1, 1999; 68(2): 301 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. M. Mueller, H. T. Tevaearai, C.-Y. Genton, P. Chaubert, and L. K. von Segesser Are there vascular density gradients along myocardial laser channels? Ann. Thorac. Surg., July 1, 1999; 68(1): 125 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lutter, M. Yoshitake, N. Takahashi, E. Nitzsche, J. Martin, K. Sarai, C. Lutz, and Friedhelm Beyersdorf Transmyocardial laser - revascularization: experimental studies on prolonged acute regional ischemia Eur. J. Cardiothorac. Surg., June 1, 1999; 13(6): 694 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lutter, J. Martin, N. Takahashi, M. Yoshitake, J. Schwarzkopf, E. Nitzsche, and F. Beyersdorf Transmyocardial laser revascularization: experimental studies in healthy porcine myocardium Ann. Thorac. Surg., June 1, 1999; 67(6): 1708 - 1713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Hughes, A. P. Kypson, J. D. St. Louis, B. H. Annex, R. E. Coleman, T. R. DeGrado, C. L. Donovan, J. E. Lowe, and K. P. Landolfo Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium Ann. Thorac. Surg., June 1, 1999; 67(6): 1714 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Misfeld, K. Szabo, E.-G. Kraatz, M. Grossherr, C. Schmidtke, M. Pilgrim, W. Kuhnel, and H. H. Sievers Electron-microscopic findings after transmyocardial laser revascularization in an acute ischemic pig model Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 398 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Hughes, J. E. Lowe, A. P. Kypson, J. D. St. Louis, A. M. Pippen, K. G. Peters, R. E. Coleman, T. R. DeGrado, C. L. Donovan, B. H. Annex, et al. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia Ann. Thorac. Surg., December 1, 1998; 66(6): 2029 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Pelletier, A. Giaid, S. Sivaraman, J. Dorfman, C. M. Li, A. Philip, and R. C.-J. Chiu Angiogenesis and growth factor expression in a model of transmyocardial revascularization Ann. Thorac. Surg., July 1, 1998; 66(1): 12 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kohmoto, C. M. DeRosa, N. Yamamoto, P. E. Fisher, P. Failey, C. R. Smith, and D. Burkhoff Evidence of Vascular Growth Associated With Laser Treatment of Normal Canine Myocardium Ann. Thorac. Surg., May 1, 1998; 65(5): 1360 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. M. Mueller, H. H. Tevaearai, C.-Y. Genton, D. Bettex, and L. K. von Segesser Transmyocardial laser revascularisation in acutely ischaemic myocardium Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 170 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Fisher, T. Khomoto, C. M. DeRosa, H. M. Spotnitz, C. R. Smith, and D. Burkhoff Histologic Analysis of Transmyocardial Channels: Comparison of CO2 and Holmium:YAG Lasers Ann. Thorac. Surg., August 1, 1997; 64(2): 466 - 472. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kohmoto, P. E. Fisher, A. Gu, S.-M. Zhu, C. M. DeRosa, C. R. Smith, and D. Burkhoff Physiology, Histology, and 2-Week Morphology of Acute Transmyocardial Channels Made With a CO2 Laser Ann. Thorac. Surg., May 1, 1997; 63(5): 1275 - 1283. [Abstract] [Full Text]
|
|
|
|
|
|
P. Whittaker and R. A. Kloner Transmural Channels as a Source of Blood Flow to Ischemic Myocardium?: Insights From the Reptilian Heart Circulation, March 18, 1997; 95(6): 1357 - 1359. [Full Text]
|
|
|
|
|
|
T. Kohmoto, M. Argenziano, N. Yamamoto, K. A. Vliet, A. Gu, C. M. DeRosa, P. E. Fisher, H. M. Spotnitz, D. Burkhoff, and C. R. Smith Assessment of Transmyocardial Perfusion in Alligator Hearts Circulation, March 18, 1997; 95(6): 1585 - 1591. [Abstract] [Full Text]
|
|
|
|
|
|
E. D. Jansen, M. Frenz, K. A. Kadipasaoglu, T. J. Pfefer, H. J. Altermatt, M. Motamedi, and A. J. Welch Laser-Tissue Interaction During Transmyocardial Laser Revascularization Ann. Thorac. Surg., March 1, 1997; 63(3): 640 - 647. [Abstract] [Full Text]
|
|
|
|
|
|
N. Gassler, H.-O. Wintzer, H.-M. Stubbe, A. Wullbrand, and U. Helmchen Transmyocardial Laser Revascularization: Histological Features in Human Nonresponder Myocardium Circulation, January 21, 1997; 95(2): 371 - 375. [Abstract] [Full Text]
|
|
|
|
|
|
P. Whittaker, J. C.-C. Tsang, and R. C.-J. Chiu Myocardial revascularization. Ann. Thorac. Surg., June 1, 1996; 61(6): 1874 - 1875. [Full Text]
|
|
|
|
|
|
P. Whittaker, R. A. Kloner, and K. Przyklenk Intramyocardial Injections and Protection Against Myocardial Ischemia : An Attempt to Examine the Cardioprotective Actions of Adenosine Circulation, June 1, 1996; 93(11): 2043 - 2051. [Abstract] [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||